Profound Medical

Profound is a medical device company that develops a minimally invasive treatment to ablate the prostate gland in prostate cancer patients.

Business Model:

Revenue: $6.9M

Employees: 11-50

Detailed Profound Medical Information

Geographic Data

Profound Medical headquarters map

Address: 2400 Skymark Avenue

City: Mississauga

State: ontario

Zip: L4W 5K6

Country: CA

Financial Info

Stage:

post ipo equity

Raised Last:

$46M

Raised Total:

$877k

Metrics

3,621,658Website Global Rank

3,684Website Monthly Traffic

Twitter Followers

Description

Profound is a medical device company that develops a minimally invasive treatment to ablate the prostate gland in prostate cancer patients.

Contact Phone:
+16474761350

Contact Email:

Profound Medical went public on 6/12/2015 on the TMX Group - Toronto Stock Exchange

Listed Exchange:
TMX Group - Toronto Stock Exchange

IPO Date:
6/12/2015

Ticker Symbol:
PRN

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
5/2011 Series A $0 Business Development Bank of Canada
BDC Venture Capital
Genesys Partners
MaRS Investment Accelerator Fund
Business Development Bank of Canada
BDC Venture Capital
Genesys Partners
MaRS Investment Accelerator Fund
4/2015 Venture Round $0 Knight Therapeutics
Genesys Venture
Genesys Capital
Mackie Research Capital Corporation
Bloom Burton &a; Co.
BDC Healthcare Venture
Cormark Securities Inc.
CTI Life Sciences Fund
GMP Securities
Knight Therapeutics
Genesys Venture
Genesys Capital
Mackie Research Capital Corporation
Bloom Burton &a; Co.
BDC Healthcare Venture
Cormark Securities Inc.
CTI Life Sciences Fund
GMP Securities
9/2017 Post-IPO Equity $8.1M
11/2016 Post-IPO Equity $12.8M
1/2020 Post-IPO Equity $40M
9/2017 Unattributed $877.5k Genesys Capital Partners Inc
1/2018 Debt Financing 1 $14.9M Armentum Partners
Armentum Partners
7/2018 IPO -
9/2019 Post-IPO Equity $11.5M
3/2018 Post-IPO Equity $0 Beacon Securities
Canaccord Genuity Group
CIBC World Markets
Echelon Wealth Partners
Mackie Research Capital Corporation
Paradigm Capital
Beacon Securities
Canaccord Genuity Group
CIBC World Markets
Echelon Wealth Partners
Mackie Research Capital Corporation
Paradigm Capital
7/2020 Post-IPO Equity $46M
1/2015 Convertible Note 2 $1.2M BDC Healthcare Venture
Genesys Venture
7/2018 IPO -

3/2018 Post-IPO Equity 6 $34.5M Beacon Securities
Canaccord Genuity Group
CIBC World Markets
Echelon Wealth Partners
Mackie Research Capital Corporation
Paradigm Capital
Beacon Securities
Canaccord Genuity Group
CIBC World Markets
Echelon Wealth Partners
Mackie Research Capital Corporation
Paradigm Capital
4/2015 Venture Round 9 $23.2M Genesys Venture
Genesys Capital
Mackie Research Capital Corporation
Genesys Venture
Genesys Capital
Mackie Research Capital Corporation
5/2011 Series A 4 $9.6M Business Development Bank of Canada
Business Development Bank of Canada
Announced Date Name Price
6/2017 Philips Sonalleve MR-HIFU business

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research